BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2000
View Archived Issues
Aminobisphosphonates activate T-cells against multiple myeloma
Read More
Cancer gene therapy with fusion molecule induces potent, selective apoptosis
Read More
Hemolink receives priority review in Canada
Read More
Myocardial gene transfer restores function to ischemic heart areas
Read More
Potent HIV protease inhibitor shows potential for use in combination therapy
Read More
GAR-936 inhibits resistant Gram-positive bacteria
Read More
Neutrophil elastase inhibitors may actually target an important host defense enzyme
Read More
Circulation rapidly restored in limbs of diabetic mice by exogenous angioblasts
Read More
Visudyne sNDA granted priority review status
Read More
THC derivative demonstrates safety, lack of marijuana-like effects in phase I trial
Read More
Alexion completes enrollment of 5G1.1 phase II study, begins open-label extension study
Read More
Novogen's lead anticancer compound continues to advance in clinical trials
Read More
Avant Immunotherapeutics obtains patent license for oral typhoid vaccine
Read More
BioSante signs license option with Antex Biologics for vaccine technology
Read More
Abbott develops potential new compounds for incontinence therapy
Read More
RXR-selective ligands offer approach to tamoxifen-resistant tumors
Read More
Magainin awarded SBIR Grant for development of asthma therapy
Read More
Viragen and Zonagen to study topical genital herpes treatment; Zonagen awarded SBIR grant
Read More
Pharmacia and Recordati collaborate on potential overactive bladder treatments
Read More
Matrix metalloproteinase inhibitors reported by Fujisawa
Read More
New series of factor Xa inhibitors claimed by Aventis
Read More
Kotobuki describes new series of cholesterol biosynthesis inhibitors
Read More
Alizyme presents new lipase inhibitors
Read More
Vascular damaging agents reported by Angiogene
Read More
New compounds interacting with CB2 receptors described by Japan Tobacco
Read More
CCR-5 receptor modulators reportedly useful for HIV infection
Read More
